Atlas Trials

A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss

Clinical trial NCT06722170 · RECRUITING

Trial details

NCT number
NCT06722170
Sponsor
Yilai Shu
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
DFNB9Congenital Hearing LossHearing Loss, Sensorineural
Start date
2024-11-22
Primary completion
2027-11-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.